$1.31
0.0050.38%
Last update: Nov 9, 4:00 PM

The average analyst price target for InflaRx is $7.56, 477.1% above the current price. Of 7 analysts, 6 rate it Buy and 1 Hold. Targets range from $2 to $14. The latest change came on Sep 14, 2026, when Needham initiated coverage of InflaRx with a Buy rating and a $8 price target.
Price Target Range — 11 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months